These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32467540)

  • 1. The effectiveness of diabetes medication therapy adherence clinic to improve glycaemic control among patients with type 2 diabetes mellitus: a randomised controlled trial.
    Alison C; Anselm S
    Med J Malaysia; 2020 May; 75(3):246-253. PubMed ID: 32467540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of pharmacist interventions, follow-up frequency and default on glycemic control in Diabetes Medication Therapy Adherence Clinic program: a multicenter study in Malaysia.
    Lim PC; Tan HH; Mohd Noor NA; Chang CT; Wong TY; Tan EL; Ong CT; Nagapa K; Tai LS; Chan WP; Sin YB; Tan YS; Velaiutham S; Mohd Hanafiah R
    J Pharm Policy Pract; 2023 Jul; 16(1):83. PubMed ID: 37408067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.
    Lim PC; Lim K; Embee ZC; Hassali MA; Thiagarajan A; Khan TM
    Pak J Pharm Sci; 2016 Mar; 29(2):595-601. PubMed ID: 27087103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Attendance to a Pharmacist-Managed Medication Adherence Clinic on Glycemic Control and Risk Factors for Non-Completion Among Persons with Type 2 Diabetes Mellitus in Selangor, Malaysia.
    Hassan F; Hatah E; Chong WW; Ali AM
    Ther Clin Risk Manag; 2024; 20():495-503. PubMed ID: 39156759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and sustainability of a structured group-based educational program (MEDIHEALTH) in improving medication adherence among Malay patients with underlying type 2 diabetes mellitus in Sarawak State of Malaysia: study protocol of a randomized controlled trial.
    Ting CY; Ahmad Zaidi Adruce S; Hassali MA; Ting H; Lim CJ; Ting RS; Abd Jabar AHA; Osman NA; Shuib IS; Loo SC; Sim ST; Lim SE; Morisky DE
    Trials; 2018 Jun; 19(1):310. PubMed ID: 29871651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a pharmacist-managed diabetes medication therapy adherence clinic.
    Lim PC; Lim K
    Pharm Pract (Granada); 2010 Oct; 8(4):250-4. PubMed ID: 25126149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a pharmacist-led structured group-based intervention in improving medication adherence and glycaemic control among type 2 diabetes mellitus patients: A randomized controlled trial.
    Ting CY; Ahmad Zaidi Adruce S; Lim CJ; Abd Jabar AHA; Ting RS; Ting H; Osman NA; Ngau E; Talin BA; Muhammad M; Loo SC; Lim SE; Hassali MA
    Res Social Adm Pharm; 2021 Feb; 17(2):344-355. PubMed ID: 32327398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of pharmacist-led collaborative care on clinical outcomes in type 2 diabetes mellitus: a multicenter randomized control trial.
    Iqbal MZ; Alqahtani SS; Mubarak N; Shahid S; Mohammed R; Mustafa A; Khan AH; Iqbal MS
    Front Public Health; 2024; 12():1323102. PubMed ID: 38476498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Diabetes Medication Therapy Adherence Clinic (DMTAC) appointment intervals on glycemic control in public health clinics across Perak, Malaysia.
    Beh YS; Gopalsamy K; Lee SLF; P Vengadasalam VP
    Malays Fam Physician; 2022 Nov; 17(3):105-113. PubMed ID: 36606164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.
    Lyons I; Barber N; Raynor DK; Wei L
    BMJ Qual Saf; 2016 Oct; 25(10):759-69. PubMed ID: 26755665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tailored consumer medicine information on patients with type 2 diabetes mellitus: A randomised controlled interventional study.
    Munsour EE; Awaisu A; Hassali MAA; Abdoun E; Dabbous Z; Zahran N; Ali H
    Int J Clin Pract; 2020 Aug; 74(8):e13527. PubMed ID: 32386077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A web-based low carbohydrate diet intervention significantly improves glycaemic control in adults with type 2 diabetes: results of the T2Diet Study randomised controlled trial.
    Dening J; Mohebbi M; Abbott G; George ES; Ball K; Islam SMS
    Nutr Diabetes; 2023 Aug; 13(1):12. PubMed ID: 37633959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
    Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M
    J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of patient characteristics on medication adherence among patients with type 2 diabetes mellitus: a cross-sectional survey.
    Abdullah NF; Khuan L; Theng CA; Sowtali SN; Juni MH
    Contemp Nurse; 2019 Feb; 55(1):27-37. PubMed ID: 30764733
    [No Abstract]   [Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication.
    Farmer AJ; Prevost AT; Hardeman W; Craven A; Sutton S; Griffin SJ; Kinmonth AL;
    BMC Fam Pract; 2008 Apr; 9():20. PubMed ID: 18405345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: A randomised controlled study.
    Butt M; Mhd Ali A; Bakry MM; Mustafa N
    Saudi Pharm J; 2016 Jan; 24(1):40-8. PubMed ID: 26903767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised-controlled trial of a web-based dietary intervention for patients with type 2 diabetes: changes in health cognitions and glycemic control.
    Ramadas A; Chan CKY; Oldenburg B; Hussein Z; Quek KF
    BMC Public Health; 2018 Jun; 18(1):716. PubMed ID: 29884161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.